
Archived App
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This app facilitates remote clinical trial management by enabling secure, HIPAA-compliant video communication and digital document handling. Patients can access study protocols, sign consent forms, and receive appointment reminders all from their mobile device.
What's New in Klinisol
1.0.5
September 5, 2021
Enhanced subdomain capacity for enterprise use, GUI improvement…
FAQ
What is Klinisol used for?
Klinisol is used for remote clinical trial management. It allows for secure video communication between study personnel and patients, digital signing of consent forms, and access to study protocols and schedules.
Is Klinisol HIPAA compliant?
Yes, Klinisol offers HIPAA-compliant video communication, ensuring that patient data and interactions are secured and encrypted according to regulatory standards.
Can I sign documents with Klinisol?
Yes, Klinisol provides the capability for patients to sign initial consent forms and other study-related documents through a 21 CFR Part 11 FDA validated account.
What devices does Klinisol support?
Klinisol is supported on iPhone, iPad, and iPod devices, allowing for mobile access to clinical trial management features.
How often is Klinisol updated?
The latest version of Klinisol is 1.0.5, and it was last updated on September 5, 2021. This indicates a recent update, suggesting ongoing development and maintenance.
What is the age rating for Klinisol?
Klinisol has an age rating of 17+, which is typical for medical and professional applications that may involve sensitive health information or complex procedures.
Does Klinisol have ads?
No, Klinisol does not contain advertisements. The application is free to use and does not display any ads to its users.
What is the rating of Klinisol?
Klinisol has a high rating of 5.0 stars based on 1 rating, indicating a very positive user experience from its early users.


